Review and Evaluation of European National Clinical Practice Guidelines for the Treatment and Management of Active Charcot Neuro-Osteoarthropathy in Diabetes Using the AGREE-II Tool Identifies an Absence of Evidence-Based Recommendations
Conclusions: European national CPGs for diabetes provide limited recommendations on active CNO. All guidelines showcased deficits in their methodology, suggesting that more rigorous methods should be employed for diabetes CPG development across Europe.
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2024/7533891 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832546240426934272 |
|---|---|
| author | Nichola Renwick Jennifer Pallin Rasmus Bo Jansen Catherine Gooday Aroa Tardáguila-Garcia Irene Sanz-Corbalán Anastasios Tentolouris Alexandra Jirkovská Armin Koller Anna Korzon-Burakowska Nina Petrova Frances Game |
| author_facet | Nichola Renwick Jennifer Pallin Rasmus Bo Jansen Catherine Gooday Aroa Tardáguila-Garcia Irene Sanz-Corbalán Anastasios Tentolouris Alexandra Jirkovská Armin Koller Anna Korzon-Burakowska Nina Petrova Frances Game |
| author_sort | Nichola Renwick |
| collection | DOAJ |
| description | Conclusions: European national CPGs for diabetes provide limited recommendations on active CNO. All guidelines showcased deficits in their methodology, suggesting that more rigorous methods should be employed for diabetes CPG development across Europe. |
| format | Article |
| id | doaj-art-f8bfe97b3c954f40a890cefcbba97a74 |
| institution | Kabale University |
| issn | 2314-6753 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Diabetes Research |
| spelling | doaj-art-f8bfe97b3c954f40a890cefcbba97a742025-02-03T07:23:38ZengWileyJournal of Diabetes Research2314-67532024-01-01202410.1155/2024/7533891Review and Evaluation of European National Clinical Practice Guidelines for the Treatment and Management of Active Charcot Neuro-Osteoarthropathy in Diabetes Using the AGREE-II Tool Identifies an Absence of Evidence-Based RecommendationsNichola Renwick0Jennifer Pallin1Rasmus Bo Jansen2Catherine Gooday3Aroa Tardáguila-Garcia4Irene Sanz-Corbalán5Anastasios Tentolouris6Alexandra Jirkovská7Armin Koller8Anna Korzon-Burakowska9Nina Petrova10Frances Game11School of Sports, Health and Exercise ScienceSchool of Public HealthBispebjerg HospitalElsie Bertram Diabetes CentreDiabetic Foot UnitDiabetic Foot UnitSchool of MedicineDiabetes CentreTechnical Orthopaedics & Diabetic Foot SurgeryDivision of Preventive Medicine & EducationDiabetic Foot ClinicDepartment of Diabetes and EndocrinologyConclusions: European national CPGs for diabetes provide limited recommendations on active CNO. All guidelines showcased deficits in their methodology, suggesting that more rigorous methods should be employed for diabetes CPG development across Europe.http://dx.doi.org/10.1155/2024/7533891 |
| spellingShingle | Nichola Renwick Jennifer Pallin Rasmus Bo Jansen Catherine Gooday Aroa Tardáguila-Garcia Irene Sanz-Corbalán Anastasios Tentolouris Alexandra Jirkovská Armin Koller Anna Korzon-Burakowska Nina Petrova Frances Game Review and Evaluation of European National Clinical Practice Guidelines for the Treatment and Management of Active Charcot Neuro-Osteoarthropathy in Diabetes Using the AGREE-II Tool Identifies an Absence of Evidence-Based Recommendations Journal of Diabetes Research |
| title | Review and Evaluation of European National Clinical Practice Guidelines for the Treatment and Management of Active Charcot Neuro-Osteoarthropathy in Diabetes Using the AGREE-II Tool Identifies an Absence of Evidence-Based Recommendations |
| title_full | Review and Evaluation of European National Clinical Practice Guidelines for the Treatment and Management of Active Charcot Neuro-Osteoarthropathy in Diabetes Using the AGREE-II Tool Identifies an Absence of Evidence-Based Recommendations |
| title_fullStr | Review and Evaluation of European National Clinical Practice Guidelines for the Treatment and Management of Active Charcot Neuro-Osteoarthropathy in Diabetes Using the AGREE-II Tool Identifies an Absence of Evidence-Based Recommendations |
| title_full_unstemmed | Review and Evaluation of European National Clinical Practice Guidelines for the Treatment and Management of Active Charcot Neuro-Osteoarthropathy in Diabetes Using the AGREE-II Tool Identifies an Absence of Evidence-Based Recommendations |
| title_short | Review and Evaluation of European National Clinical Practice Guidelines for the Treatment and Management of Active Charcot Neuro-Osteoarthropathy in Diabetes Using the AGREE-II Tool Identifies an Absence of Evidence-Based Recommendations |
| title_sort | review and evaluation of european national clinical practice guidelines for the treatment and management of active charcot neuro osteoarthropathy in diabetes using the agree ii tool identifies an absence of evidence based recommendations |
| url | http://dx.doi.org/10.1155/2024/7533891 |
| work_keys_str_mv | AT nicholarenwick reviewandevaluationofeuropeannationalclinicalpracticeguidelinesforthetreatmentandmanagementofactivecharcotneuroosteoarthropathyindiabetesusingtheagreeiitoolidentifiesanabsenceofevidencebasedrecommendations AT jenniferpallin reviewandevaluationofeuropeannationalclinicalpracticeguidelinesforthetreatmentandmanagementofactivecharcotneuroosteoarthropathyindiabetesusingtheagreeiitoolidentifiesanabsenceofevidencebasedrecommendations AT rasmusbojansen reviewandevaluationofeuropeannationalclinicalpracticeguidelinesforthetreatmentandmanagementofactivecharcotneuroosteoarthropathyindiabetesusingtheagreeiitoolidentifiesanabsenceofevidencebasedrecommendations AT catherinegooday reviewandevaluationofeuropeannationalclinicalpracticeguidelinesforthetreatmentandmanagementofactivecharcotneuroosteoarthropathyindiabetesusingtheagreeiitoolidentifiesanabsenceofevidencebasedrecommendations AT aroatardaguilagarcia reviewandevaluationofeuropeannationalclinicalpracticeguidelinesforthetreatmentandmanagementofactivecharcotneuroosteoarthropathyindiabetesusingtheagreeiitoolidentifiesanabsenceofevidencebasedrecommendations AT irenesanzcorbalan reviewandevaluationofeuropeannationalclinicalpracticeguidelinesforthetreatmentandmanagementofactivecharcotneuroosteoarthropathyindiabetesusingtheagreeiitoolidentifiesanabsenceofevidencebasedrecommendations AT anastasiostentolouris reviewandevaluationofeuropeannationalclinicalpracticeguidelinesforthetreatmentandmanagementofactivecharcotneuroosteoarthropathyindiabetesusingtheagreeiitoolidentifiesanabsenceofevidencebasedrecommendations AT alexandrajirkovska reviewandevaluationofeuropeannationalclinicalpracticeguidelinesforthetreatmentandmanagementofactivecharcotneuroosteoarthropathyindiabetesusingtheagreeiitoolidentifiesanabsenceofevidencebasedrecommendations AT arminkoller reviewandevaluationofeuropeannationalclinicalpracticeguidelinesforthetreatmentandmanagementofactivecharcotneuroosteoarthropathyindiabetesusingtheagreeiitoolidentifiesanabsenceofevidencebasedrecommendations AT annakorzonburakowska reviewandevaluationofeuropeannationalclinicalpracticeguidelinesforthetreatmentandmanagementofactivecharcotneuroosteoarthropathyindiabetesusingtheagreeiitoolidentifiesanabsenceofevidencebasedrecommendations AT ninapetrova reviewandevaluationofeuropeannationalclinicalpracticeguidelinesforthetreatmentandmanagementofactivecharcotneuroosteoarthropathyindiabetesusingtheagreeiitoolidentifiesanabsenceofevidencebasedrecommendations AT francesgame reviewandevaluationofeuropeannationalclinicalpracticeguidelinesforthetreatmentandmanagementofactivecharcotneuroosteoarthropathyindiabetesusingtheagreeiitoolidentifiesanabsenceofevidencebasedrecommendations |